Research Continuity Planning for COVID-19


Below are funding opportunities specific to the novel coronavirus (COVID-19), inclusive of federal, foundations, and other related prizes and awards eligible to the University of Chicago. Opportunities are listed by impending funding opportunity deadlines. This list is updated as new opportunities are announced. If you would like to add to this list, please email Beth Ziolkowski at

Interested in doing research relating to COVID-19?
Submit your idea through this Research Intake Form.

Last updated October 8, 2021

NEW!AgencyFunding OpportunitySubmit through (Deadline)Funding Amount (Upper)
NIH, NCATS, NCCIH, NCI, NHGRI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDCD, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINR, NLM, ORWH, OSCEmergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)VariousBudgets are not limited
NIH, NCATSNotice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)VariousVarious
NIH, NCATSNotice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath NeedVariousVarious
National Institutes of Health, NCI, NCCIH, NHGRI, NIAID, NICHD, NIDDK, NIEHS, NIGMS, NIMHD, NIBIBEmergency Competitive Revision to Existing NIH Awards (Emergency Supplement – Clinical Trial Optional)See Emergency Notice of Special Interest by ICBudgets are not limited
Draper Richards Kaplan FoundationCoronavirus Urgent Response InitiativeNone Specified$100,000 (invests 25% maximum of total budget)
Mercatus Center of George Mason UniversityCOVID-19 Response: A Call for IdeasNone SpecifiedBudgets are not limited
NIH, NIMHNotice Announcing the Availability of Common Data Elements for Research Related to the Public Health Emergency caused by Coronavirus Disease 2019 (COVID-19)None SpecifiedNone Specified
Biogen FoundationBiogen Foundation’s COVID-19 ResponseNone SpecifiedNone Specified
NSFDear Colleague Letter: Sentinel Cells for Surveillance and Response to Emergent Infectious Diseases (Sentinels)None SpecifiedNone Specified
Bristol Myers SquibbBristol Myers Squibb Independent Research Applications (across all therapeutic areas)None SpecifiedNone Specified
CETFCOVID-19 Early Treatment Fund (CETF)None SpecifiedNone Specified
Open Road AllianceOpen Road’s COVID-19 ResponseNone SpecifiedNone Specified
AmgenAmgen COVID-19 GrantsNone SpecifiedNone Specified
LecronaInvestigator Initiated Studies (COVID-19: safety, clinical outcomes, antiviral effects, or antithrombotic benefits)None SpecifiedNone Specified
Autism Speaks COVID-19 Grand Challenge Reg - 10/25/2020 (App - 11/05/2020) 200,000 Not specified
Autism Research COVID-19 Call for Resources
None Specified None Specified
Department of Commerce, Economic Development AdministrationFY 2020 EDA Public Works and Economic Adjustment Assistance Programs including CARES Act FundingContinuous $30,000,000
Defense Logistics AgencyRequest for White Papers: COVID-19 Prototype PPE and Decontamination EquipmentContinuous$1,000,000
CETFCOVID-19 Early Treatment FundContinuous$1,000,000
NIH, NIADNotice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2Continuous$500,000/year
Biomedical Advanced Research and Development Authority (BARDA)Continuous$750,000
National Science FoundationNSF Rapid Release Funding MechanismContinuous$200,000
NASARapid Response and Novel Research in Earth Science (see NASA ROSES solicitation)Continuous$150,000
Merck KGaAResearch Grant for Pandemic PreparednessContinuous500,000 EUR
Google COVID-19 Research Grants Google Cloud COVID-19 Research GrantsContinuousBudgets are not limited
Jacob and Valeria Langeloth FoundationCOVID-19 Rapid Response FundContinuousBudgets are not limited
Robert Wood Johnson FoundationPioneering Ideas: Exploring the Future to Build a Culture of HealthContinuousBudgets are not limited (past average grant $315,000)
CiscoPandemic/COVID19 Science, Technology and Social ImpactContinuousBudgets are not limited
NIH, NIAIDLimited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed)ContinuousBudgets are not limited
NIH, ORWH, NICHDNotice of Special Interest: Emerging Viral Infections and their Impact on the Male and Female Reproductive TractContinuousNone specified
ForeFrontForefront COVID-19 Response FundsContinuousNone Specified
US ArmyArmy Applications Lab: Call for COVID-19 ProposalsContinuousNone Specified
The COVID-19 High Performance Computing (HPC) ConsortiumThe COVID-19 High Performance Computing ConsortiumContinuousNone Specified
Bill and Melinda Gates FoundationCOVID-19 Therapeutics AcceleratorContinuousNone Specified
NIH, NIMHD, NCI, NIDA, NLM, ODP, OBSSR, NIMH, NIAMSNotice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health DisparitiesContinuousNone Specified
Council on Foundation’s Covid-19 PledgeA Call to Action Philanthropy's Commitment During COVID-19 ContinuousNone Specified
Amazon Web ServicesAWS Diagnostic Development Initiative (DDI)ContinuousNone specified (less than $20 million)
NIH, NHLBINotice of Special Interest (NOSI): The Influence of Host Resilience on Heterogeneity of Acute Respiratory Distress Syndrome/Acute Lung Injury (ARDS/ALI)07/05/2024None Specified
NIH, NICHDNotice of Special Interest (NOSI): Promoting Vaccine Access, Acceptance and Uptake among Children, Adolescents, Pregnant and Lactating Women, and Persons with Disabilities05/08/2024None Specified
NIH, HHSNotice of Special Interest (NOSI) HIV/AIDS in the Era of COVID-19: When Pandemics Collide05/07/2024None Specified
NIH, HHSNotice of Special Interest (NOSI): NIDCR Support for Research on the Physiological Involvement of Oral Cavity in Coronavirus Disease 2019 (COVID-19) 05/08/2023None Specified
NIH, HHSNotice of Special Interest (NOSI): Neurological and Neurocognitive Sequelae from SARS-CoV-2 Infection and COVID-19 in Aging and Age-Related Neurodegeneration05/7/2023None Specified
NIH NIDCDNotice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders09/08/2022Budgets are not limited
NIH, NIDCDNotice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders09/07/2022None Specified
NIH, NCATSEmergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus01/26/2022Must not Exceed Parent Award
NIH, NCATSNotice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel CoronavirusE01/25/2022Limited to no more than the amount of the current parent award
NIH, HHSAntiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern (U19 Clinical Trial Not Allowed)10/22/2021$15,000,000
NIH, NIOSHNIOSH Centers of Excellence for Total Worker Health® (U19) - LIMITED02/03/2021; 10/29/2021; 10/28/2022; 10/30/2023$1,400,000
DOE, DARPAAssessing Immune Memory (AIM) 9/9/2021; 10/26/2021None Specified
HHS, FDAInnovation Award: COVID-19 and Health Equity (U01) Clinical Trials Optional11/29/2021$1,000,000